Bill
A 3674
Summary of Bill A 3674Bill Number: A 3674 Title: Relates to extending provisions of law relating to the New York State Adult Cystic Fibrosis Program Status: Referred to Health I
Bill Number: A 3674
Title: Relates to extending provisions of law relating to the New York State Adult Cystic Fibrosis Program
Status: Referred to Health
Introduced: January 29, 2025
Classification: Bill
Bill A 3674 aims to extend the provisions of existing laws that govern the New York State Adult Cystic Fibrosis Program. The primary intent of this legislation is to ensure continued support and resources for adults living with cystic fibrosis, a genetic disorder that affects the lungs and digestive system. By extending these provisions, the bill seeks to enhance the quality of care and improve health outcomes for individuals affected by this condition.
While the specific text of the bill is not detailed in the provided information, the following key provisions can be anticipated based on the context of similar legislation:
Extension of Program Duration: The bill likely proposes to extend the operational timeline of the Adult Cystic Fibrosis Program, ensuring that funding and resources remain available for ongoing patient support.
Funding Allocation: It may include provisions for the allocation of state funds to support the program, which could cover medical treatments, patient education, and support services.
Access to Care: The bill may aim to improve access to specialized care for adults with cystic fibrosis, potentially including partnerships with healthcare providers and institutions.
The primary beneficiaries of Bill A 3674 would be:
Adults with Cystic Fibrosis: Individuals diagnosed with cystic fibrosis who require ongoing medical care and support services.
Healthcare Providers: Medical professionals and institutions that specialize in the treatment of cystic fibrosis, who would receive support through the program.
Families and Caregivers: Families of affected individuals who rely on the program for resources and assistance in managing the condition.
Legislative Action: The bill was introduced on January 29, 2025, and has been referred to the Health Committee for further consideration.
Sponsorship: The bill is sponsored by Stacey Pheffer Amato, with cosponsors including Judy Griffin, John T. McDonald III, and Grace Lee, indicating a collaborative effort to address the needs of the cystic fibrosis community.
Related Legislation: This bill is related to prior-session Bill A 8515 and has a companion bill in the Senate, S 3320, which may provide additional context or support for the proposed measures.
Bill A 3674 represents a significant step towards ensuring that adults with cystic fibrosis in New York State continue to receive the necessary support and resources. By extending the provisions of the Adult Cystic Fibrosis Program, the bill aims to improve health outcomes and quality of life for those affected by this chronic condition. Further developments will depend on the outcomes of discussions within the Health Committee and subsequent legislative actions.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
